K.A. Papp, R.G. Langley, B. Sigurgeirsson, M. Abe, D.R. Baker, P. Konno, S. Haemmerle, H.J. Thurston, C. Papavassilis and H.B. Richards Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study British Journal of Dermatology 168
Version of Record online: 18 JAN 2013 | DOI: 10.1111/bjd.12110
What’s already known about this topic?
What does this study add?
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field